BITBIOME - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 79275265
Serial Number
79275265
Registration Number
6291515
Word Mark
BITBIOME
Status
700 - Registered
Status Date
2021-03-16
Filing Date
2019-07-25
Registration Number
6291515
Registration Date
2021-03-16
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form Typeset
Published for Opposition Date
2020-12-29
Attorney Name
Law Office Assigned Location Code
M60
Employee Name
FLETCHER, TRACY L
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Goods and Services
Pharmaceutical preparations for the treatment of allergies, alzheimer disease, adrenocortical insufficiency, allotype pneumonia, alveobronchiolitis, angiocholitis, arthritis, asthmatoid bronchitis, asthma, attention deficit hyperactivity disorder, autism, auto-immune diseases and disorders, autoinflammatory disease, bacteremia, bacterial infection, bacterial pneumonia, bacterial septicemia, bacteroides fragilis, bacteroides thetaiotaomicron, bacteroides uniformis, bacteroides vulgatus, beta thalassemia and myelodysplastic syndromes, and biliary tract cancer, pneumonia, blood disease, blood disorders, bone growth disorders, bone and joint infections, breast cancer, bronchitis, bronchiectasis, cancer, cardiovascular diseases, central nervous system diseases and disorders, cervical cancer, cholecystitis, chronic congestive heart failure, clostridium perfringens, collagen diseases, colorectal cancer, community-acquired pneumonia, congestive heart failure, constipation, crohn's disease, cystitis, deep suppurative disease, dementia, depression, diabetes, dermatologic diseases, duodenal ulcer, dysentery, edematous states, endocarditis, endocrine diseases and disorders, endometrial cancer, endometriosis, endonephritis, enteritis, enterococcus faecalis, epididymitis, epilepsy, esophageal cancer, dysentery, febrile neutropenic infections, gastrointestinal diseases and disorders, gastric cancer, gastric ulcer, genetic diseases and disorders, gonorrhea, graft-versus-host disease, granulocytopenia, gynecological infections, head and neck cancer, heart disease, hematologic disorders, hepatic cirrhosis, hypertension, hyperlipidemi, hypercholesterolemia, hypognathadenitis, incontinence, inflammation and inflammatory diseases, inflammatory bowel disease, intra-abdominal infections, intrauterine infection, irritable bowel syndrome, kidney diseases and disorders, leukemia, liver disorders and diseases, lower respiratory tract infections, lung cancer, lymphoma, melanoma, meningitis, menopausal, metabolic diseases and disorders, multiple myeloma, multiple sclerosis, muscular dystrophy, musculoskeletal diseases and disorders, myeloproliferative diseases, myelofibrosis, nasosinusitis, neoplastic diseases, neurodegenerative diseases and disorders, neurological diseases and disorders, neuromuscular and non-gonococcal urethritis, nosocomial pneumonia, obesity, obsessive-compulsive disorder, oncological diseases and disorders, ophthalmic diseases, osteoarthritis, otitis media, ovarian cancer, pain, pancreatic cancer, parkinson's disease, peptostreptococcus micros, peritonitis and septicemia, pneumonia, polymicrobic infections, prevention of chest pain, prostate cancer, prostatitis, pseudomonas aeruginosa, pyelocystiti, pyelonephritis, reflux sophagitis, renal dysfunction, rheumatic disorders, respiratory diseases, respiratory tract infections, schizophrenia, scleroderma, seizures, septicemia, sexual disfunction, sickle cell disease, skin disorders and diseases, skin and skin structure infections, solid organ transplant rejection, spasms, staphylococcus aureus, streptococcus anginosus, streptococcus intermadius, streptococcus constellatus, stroke, superficial pyogenic infection, suppurative lung disease, syphilis, transmissible alimentary toxicosis, the prevention of organ rejection by renal transplant patients, tumors, ulcerative colitis, urethritis, urinary tract infections, urogenital tract infection, urothelial cancer, vaso-occulisive crisis, viral diseases and disorders, and zollinger-ellison syndrome; pharmaceutical biological preparations for medical purposes for the treatment of allergies, alzheimer disease, adrenocortical insufficiency, allotype pneumonia, alveobronchiolitis, angiocholitis, arthritis, asthmatoid bronchitis, asthma, attention deficit hyperactivity disorder, autism, auto-immune diseases and disorders, autoinflammatory disease, bacteremia, bacterial infection, bacterial pneumonia, bacterial septicemia, bacteroides fragilis, bacteroides thetaiotaomicron, bacteroides uniformis, bacteroides vulgatus, beta thalassemia and myelodysplastic syndromes, biliary tract cancer, pneumonia, blood disease, blood disorders, bone growth disorders, bone and joint infections, breast cancer, bronchitis, bronchiectasis, cancer, cardiovascular diseases, central nervous system diseases and disorders, cervical cancer, cholecystitis, chronic congestive heart failure, clostridium perfringens, collagen diseases, colorectal cancer, community-acquired pneumonia, congestive heart failure, constipation, crohn's disease, cystitis, deep suppurative disease, dementia, depression, diabetes, dermatologic diseases, duodenal ulcer, dysentery, edematous states, endocarditis, endocrine diseases and disorders, endometrial cancer, endometriosis, endonephritis, enteritis, enterococcus faecalis, epididymitis, epilepsy, esophageal cancer, dysentery, febrile neutropenic infections, gastrointestinal diseases and disorders, gastric cancer, gastric ulcer, genetic diseases and disorders, gonorrhea, graft-versus-host disease, granulocytopenia, gynecological infections, head and neck cancer, heart disease, hematologic disorders, hepatic cirrhosis, hypertension, hyperlipidemi, hypercholesterolemia, hypognathadenitis, incontinence, inflammation and inflammatory diseases, inflammatory bowel disease, intra-abdominal infections, intrauterine infection, irritable bowel syndrome, kidney diseases and disorders, leukemia, liver disorders and diseases, lower respiratory tract infections, lung cancer, lymphoma, melanoma, meningitis, menopausal, metabolic diseases and disorders, multiple myeloma, multiple sclerosis, muscular dystrophy, musculoskeletal diseases and disorders, myeloproliferative diseases, myelofibrosis, nasosinusitis, neoplastic diseases, neurodegenerative diseases and disorders, neurological diseases and disorders, neuromuscular and non-gonococcal urethritis, nosocomial pneumonia, obesity, obsessive-compulsive disorder, oncological diseases and disorders, ophthalmic diseases, osteoarthritis, otitis media, ovarian cancer, pain, pancreatic cancer, parkinson's disease, peptostreptococcus micros, peritonitis and septicemia, pneumonia, polymicrobic infections, prevention of chest pain, prostate cancer, prostatitis, pseudomonas aeruginosa, pyelocystiti, pyelonephritis, reflux sophagitis, renal dysfunction, rheumatic disorders, respiratory diseases, respiratory tract infections, schizophrenia, scleroderma, seizures, septicemia, sexual disfunction, sickle cell disease, skin disorders and diseases, skin and skin structure infections, solid organ transplant rejection, spasms, staphylococcus aureus, streptococcus anginosus, streptococcus intermadius, streptococcus constellatus, stroke, superficial pyogenic infection, suppurative lung disease, syphilis, transmissible alimentary toxicosis, the prevention of organ rejection by renal transplant patients, tumors, ulcerative colitis, urethritis, urinary tract infections, urogenital tract infection, urothelial cancer, vaso-occulisive crisis, viral diseases and disorders, and zollinger-ellison syndrome; pharmaceutical preparations for human use, namely, analgesics, antibiotics, anti-fungals, anti-infective preparations, anti-virals, anti-parasitics, and cytokine inhibitory drugs; human growth hormones, immunosuppressants, immunotherapies for the treatment of cancer, medicated dermatological preparations, pharmaceutical antibodies for disease testing, diagnosis, and treatment purposes, pharmaceutical preparations that modulate the immune system, pharmaceutical and biological preparations for immunotherapy, including T Cell therapy, sedatives, smoking cessation preparations, tranquillizers, vaccines for human use, and vitamins; and preparations for destroying vermin, fungicides, herbicides
Goods and Services
Structural and functional analysis of genomes; research and development in the field of microorganisms and cells for the healthcare, scientific, biochemical, pharmaceutical, medical, agricultural, food, cosmetic, animal health, diagnostic, chemical, bioremediation, sanitation, oral care, and oil industries; pharmaceutical research and development; pharmaceutical product evaluation services; medical research; medical laboratory services; genetic testing for scientific research purposes
Goods and Services
Medical screening; providing information relating to medical services; genetic testing for medical purposes
Pseudo Mark
BIT BIOME
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-01-07
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-01-07
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-01-07
Primary Code
044
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Stacey J. Watson
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1506253
International Registration Date
2019-07-25
International Publication Date
2019-12-26
International Renewal Date
2029-07-25
Auto Protection Date
2021-06-26
International Status
001 - Request for extension of protection established
International Status Date
2019-12-26
Priority Claimed In
True
Priority Claimed Date
2019-01-30
First Refusal In
True
Trademark Events
Event DateEvent Description
2019-12-26SN ASSIGNED FOR SECT 66A APPL FROM IB
2020-01-07NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2020-01-07ASSIGNED TO EXAMINER
2020-01-10NON-FINAL ACTION WRITTEN
2020-01-11APPLICATION FILING RECEIPT MAILED
2020-01-11NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2020-02-07REFUSAL PROCESSED BY MPU
2020-02-07NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2020-02-28REFUSAL PROCESSED BY IB
2020-07-10TEAS CHANGE OF OWNER ADDRESS RECEIVED
2020-07-10TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2020-07-10ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-07-10TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
2020-07-10TEAS CHANGE OF CORRESPONDENCE RECEIVED
2020-07-10APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2020-08-04TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-08-21ASSIGNED TO LIE
2020-08-24APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2020-08-24CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-08-24TEAS/EMAIL CORRESPONDENCE ENTERED
2020-08-28NON-FINAL ACTION WRITTEN
2020-08-28NON-FINAL ACTION E-MAILED
2020-08-28NOTIFICATION OF NON-FINAL ACTION E-MAILED
2020-11-12EXAMINERS AMENDMENT -WRITTEN
2020-11-12EXAMINERS AMENDMENT E-MAILED
2020-11-12NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2020-11-19EXAMINER'S AMENDMENT ENTERED
2020-11-19APPROVED FOR PUB - PRINCIPAL REGISTER
2020-12-09NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2020-12-23NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
2020-12-23NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2020-12-29PUBLISHED FOR OPPOSITION
2020-12-29OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2021-01-10NOTIFICATION PROCESSED BY IB
2021-03-16REGISTERED-PRINCIPAL REGISTER
2021-06-16FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2021-06-17FINAL DISPOSITION PROCESSED
2021-06-17FINAL DISPOSITION NOTICE SENT TO IB
2021-07-11FINAL DECISION TRANSACTION PROCESSED BY IB